Takeda Pharmaceutical Company Limited | TalkMarkets | Page 1
No data available
No data available

People who follow this stock (24)

View All

Latest Posts

About This Stock More About This Stock
Week In Review: Samsung Biologics Signs $1 Billion Manufacturing Contract With US Biopharma
Article By: ChinaBio® Today
Saturday, July 6, 2024 1:20 PM EDT
Samsung Biologics, a Korean CDMO, signed a $1.06 billion agreement to provide manufacturing services for an unnamed US pharma. The agreement is the largest that Samsung Bio has made since it was founded in 2011.
In this article: TAK, IVBXF, ESAIY Also: AMGN
Read
Week In Review: Osaka Enters $445 Million Deal For Two Hearing Loss Candidates From France's Cilcare
Article By: ChinaBio® Today
Saturday, June 15, 2024 1:40 PM EDT
Shionogi, an Osaka innovative pharma, has signed an option agreement with Cilcare of France to in-license two drug candidates aimed at hearing loss in a deal worth up to $445 million. Meanwhile, XtalPi raised $126.8 million in a Hong Kong IPO.
In this article: KYKOF, SGIOF, ZYME, TAK, ASPHF Also: BGNE
Read
Week In Review: Hengrui And Degron Announce $7.2 Billion In Drug Licensings
Article By: ChinaBio® Today
Saturday, May 25, 2024 4:00 PM EDT
Jiangsu Hengrui Medicine out-licensed global rights for its portfolio of three proprietary GLP-1 candidates to a US startup, Hercules, in a deal worth up to $6 billion. Hengrui will receive $110 million upfront and up to $200 million in milestones.
In this article: AZN, BGNE, TAK, IVBXF, CSPHF
Read
Week In Review: Takeda Options Alzheimer's Therapy From AC Immune In $2.2 Billion Deal
Article By: ChinaBio® Today
Sunday, May 19, 2024 7:14 PM EDT
In the headline deal, Takeda acquires global rights from AC Immune of Switzerland for $100 million upfront and up to $2.1B in milestones.
In this article: SLGL, TAK
Read
More Than 140 Drug Brands Will Have Their Prices Hiked Heading Into 2024
Article By: Tyler Durden
Thursday, January 4, 2024 1:10 AM EDT
More than 140 brands of drugs are going to see their prices hiked heading into the new year
In this article: GSK, PFE, SNY, TAK
Read
All Posts

Latest Tweets for $TAK

No tweets yet!

PARTNER HEADLINES